12:43 PM EDT, 09/30/2024 (MT Newswires) -- Kimberly-Clark ( KMB ) is mulling its options for its international tissue business as part of a strategy to focus on more profitable areas, Bloomberg reported Monday, citing people familiar with the matter.

The company is working with advisers to review its non-North American tissue business, which could lead to a sale of part or all of the operation, the people reportedly told Bloomberg. A sale could value the business at around $4 billion, according to the news outlet, citing the people.

Kimberly-Clark ( KMB ) did not immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 142.01, Change: -0.53, Percent Change: -0.37